As we mark our 50th year of service to YOU, the ABTA is excited to announce “Meet Hope Head On,” a five-year campaign to accelerate our collective vision of a world in which not one life is lost to a brain tumor.
Why this campaign, now? Simply put, more must be done.
Many survivors told us, “We need more grey ribbons. We need more awareness!” Patients and caregivers continue to urge us that “we need more treatment options than just Temodar.” And leading researchers keep telling us that “progress has been made, but we must do even more, faster.”
We couldn’t agree more.
Our goal over the next five years is to secure $50 million to:
- Triple our funding of brain tumor research
- Double the number of patients, survivors and caregivers we serve
- Activate grassroots advocacy and public policy initiatives
You can play a key role in this campaign. The time is now!
Click below to learn how you can “Meet Hope Head On.”
Jessie Schlacks
Jessie is Managing Editor of the bi-monthly e-newsletter MindMatters. Submit story ideas or questions to jschlacks@abta.org.
About Meet Hope Head On
Because of the generous support from people like you, the ABTA has given over $35 million for brain tumor research. The ABTA’s campaign, “Meet Hope Head On,” created for our 50th anniversary, is focused on raising $50 million, in part to fund critical brain tumor research. This campaign is vital for continuing the kind of work that led to the recent FDA approval of vorasidenib, a breakthrough treatment for low-grade glioma.
